Summit Trail Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
VCM
DAM
VPM
Summit Trail Advisors's CL Position: Q1 2026 in Review
Summit Trail Advisors increased its Colgate-Palmolive (CL) stake by 24% in Q1 2026, buying an estimated $1.19M and bringing the position to 68,417 shares worth $5.83M. The position accounts for 0.08% of the portfolio, ranked #137.
Summit Trail Advisors first reported a position in CL in Q4 2017 and has held it in 13 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Summit Trail Advisors held 68,417 shares of Colgate-Palmolive worth $5.83M as of Q1 2026.
- Summit Trail Advisors bought 13,331 Colgate-Palmolive shares in Q1 2026, an estimated $1.19M.
- Colgate-Palmolive made up 0.08% of Summit Trail Advisors's portfolio in Q1 2026, its #137 holding.
- Summit Trail Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 13 quarters since.
- 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.